Use of Warfarin After the First Trimester in Pregnant Women With APS

  • days left to enroll
  • participants needed
  • sponsor
    Mohamed Sayed Abdelhafez
Updated on 24 January 2021
vitamin k antagonist
early pregnancy
antiphospholipid syndrome


Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with antiphospholipid syndrome (APS)


Women will be randomly divided into two groups; one will be subjected to anticoagulant therapy by Enoxaparin throughout pregnancy and the other will be subjected to anticoagulant therapy by Enoxaparin in the first trimester then Warfarin after the first trimester until termination of pregnancy.

Condition Antiphospholipid Syndrome, Autoimmune disease, habitual abortion, Spontaneous abortion, Miscarriage, recurrent miscarriage, recurrent abortions
Treatment Warfarin, Enoxaparin
Clinical Study IdentifierNCT02303171
SponsorMohamed Sayed Abdelhafez
Last Modified on24 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age between 20 yrs and 38 yrs?
Are you female?
Do you have any of these conditions: Miscarriage or recurrent miscarriage or Spontaneous abortion or recurrent abortions or Autoimmune disease or habitual abortion or Antiphospholipid Syn...?
Pregnant women with APS diagnosed according to the revised classification criteria for APS in 2006 in Sydney, Australia
Early pregnancy body weight is 50-90 Kg

Exclusion Criteria

Women with systemic lupus erythematosus (SLE)
Women with active thromboembolic disorders
Women with history of previous thromboembolic disorders
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note